cid:image001.jpg@01D158FE.B69B8D00
Hello everyone,
As many of you know, Dr. Jean-Eric Ghia has been highlighting local
researchers on his Ici Radio Canada show Des éprouvettes et des hommes for
the last several years, and he has now moved on to television! Check out
the latest episode of his new feature "Quest-ce qu'on cherche?, which
aired February 23rd on the Ici Radio Canada TV program Téléjournal. In this
segment, he visited the lab of MNN member Dr. Paul Fernyhough to discuss
diabetic neuropathy. Do you have exciting new findings that you would like
to share with the public? Contact Jean-Eric to inquire about being his
next guest!
https://www.facebook.com/icimanitoba/videos/10154521472633195/
<https://www.facebook.com/icimanitoba/videos/10154521472633195/> ICI
Manitoba - Aujourd'hui dans la rubrique « Qu'est ce... | Facebook
www.facebook.com
Aujourd'hui dans la rubrique « Qu'est ce qu'on cherche », Jean-Eric Ghia
nous emmène au Centre de recherche de Saint-Boniface pour nous faire
découvrir...
Please join me in congratulating Jean-Eric on his success and for the great
efforts that he has made to promote science in the Francophone community!
Best wishes, Sari
Sari S. Hannila, PhD
Director of Outreach, Manitoba Neuroscience Network
cid:image004.jpg@01D158FE.B69B8D00
cid:image001.jpg@01D158FE.B69B8D00
Hello everyone,
The MNN is pleased to be hosting Dr. Luda Diatchenko from McGill University
as our featured speaker for Brain Awareness Week 2017. Dr. Diatchenko holds
the Canada Excellence Research Chair in Human Pain Genetics, and she has
made significant contributions to our understanding of how human genetic
variability influences pain sensitivity and chronic pain states. Her work
incorporates molecular, genetic, and psychological methods, and one of the
primary goals of her research is to develop individualized treatments for
pain.
Dr. Diatchenko will be giving her talk on Monday, March 13th, at 12:00 pm in
Theatre B. She is also available for one-on-one meetings during the day,
including a breakfast meeting at 8 am. To request a meeting, please email
Kae Normandeau: Kae.Normandeau(a)umanitoba.ca
If you have any interest in the pain field, this is a great opportunity to
speak to one of its leaders.
Best wishes, Sari
Sari S. Hannila, PhD
Director of Outreach, Manitoba Neuroscience Network
cid:image004.jpg@01D158FE.B69B8D00
S E M I N A R & V I S I T I N G S P E A K E R S E R I E S
D AT E
Friday, February 24, 2017 9:00AM
LO C AT I O N
PX236/238 PsychHealth Building
S P E A K E R
Dr. Stephanie Booth
Adjunct Professor - Department of Medical Microbiology & Infectious
Diseases,
University of Manitoba
Chief - Molecular PathoBiology, National Microbiology Laboratory,
Public Health Agency of Canada
Topic: Untangling the brains neurodegenerative transcriptional response in
presymptomatic prion disease
ABSTRACT
Neurite degeneration represents a common characteristic of neurodegenerative
diseases including those caused by prions. In fact, in mouse models the
loss of dendritic spines and reduction in neurite outgrowth is one of the
earliest pathological changes observed in vivo. However, the underlying
mechanisms that regulate these processes remain elusive. By harnessing laser
capture microdissection to specifically isolate neuronal cell bodies from
the hippocampus we were able to identify genes and miRNAs miRs) that are
induced during preclinical prion disease. A functional genomics approach in
primary hippocampal neurons suggests that these miRs regulate degeneration
of neurites in these cells. Targeted transcriptional profiling has great
potential to identify both therapeutic targets for patients with prion
disease, as well as early markers of prion infection that may be
translatable to other neurodegenerative diseases.
/sent on behalf of
Eftekhar Eftekhapour
Coordinator, Seminar & Visiting Speaker Program
Manitoba Neuroscience Network
Email: networking(a)manitobaneuroscience.ca
<mailto:networking@manitobaneuroscience.ca>
Tel: 204.235.3939
Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA
******************************************
<http://www.manitobaneuroscience.ca/>
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
<https://www.instagram.com/manitobaneuroscience/>
<https://twitter.com/manitobaneuro>
cid:image001.jpg@01D158FE.B69B8D00
Hello everyone,
The MNN, together with the Manitoba Craft Council, is thrilled to announce
that our Neurocraft art exhibition will be on view March 3rd to 31st in the
John Buhler Research Centre Atrium at the University of Manitobas Bannatyne
campus!
Please join us for the opening reception, which will be held Friday, March
3rd, from 7-10 pm in the JBRC Atrium. There will be free food, a cash bar,
beautiful art to see, and lots of interesting people to meet! Spouses,
children, and friends are all welcome! If you are on Facebook, you can find
the event here: https://www.facebook.com/events/213429172459233/ . Please
feel free to invite people!
Follow us on Twitter (@manitobaneuro) and Instagram (@manitobaneuroscience)
for updates on Neurocraft, and stay tuned for more news about our upcoming
Brain Awareness Week events, including a special lecture by Canada
Excellence Research Chair Dr. Luda Diatchenko, a panel discussion at the
Winnipeg Free Press Café, and a craft workshop with one of our Neurocraft
artists!
As always, thank you for your support of the MNN and our outreach
initiatives.
Best wishes, Sari
Sari S. Hannila, PhD
Director of Outreach, Manitoba Neuroscience Network
cid:image004.jpg@01D158FE.B69B8D00
Visiting Speaker & Seminar Series
Friday, February 10, 2017
12:00 NOON.
Apotex Theatre 071, Bannatyne Campus
Dr. James Eubanks
Senior Scientist - Krembil Research Institute Professor - Department of
Surgery,
University of Toronto
Enhancing Excitation To Combat Lost Silencing: Therapeutic Considerations
For Rett Syndrome
***FOLLOWED BY A "NEUROSCIENCE TRAINEE LUNCH" IN SR415 Kleysen Bldg.
BIO: The primary interests of my group relate to defining how the absence of
either methyl DNA binding factor MeCP2, or more recently CDKL5, affects
normal brain function and/or alters the normal progression of brain
development, and to identifying strategies that can be used to correct the
observed alterations. Our work encompasses generating novel transgenic mouse
lines that can be used to address questions relating to our focus, to
testing novel pharmacological agents in established models of Rett syndrome
as part of translational efforts. We are well positioned to assess
therapeutically meaningful endpoints for the translational studies, and have
the skills needed to identify key deficits that can then be subsequently
targeted. It is our intention to identify novel strategies that can someday
be employed to treat patients with Rett syndrome, with the ultimate goal
being condition correction. Our current investigations span several research
disciplines, including cell biology, pharmacology, electrophysiology,
molecular genetics, animal behavior, and live cell imaging.
/sent on behalf of
Dr. Eftekhar Eftekharpour
Coordinator - MNN Visiting Speaker & Seminar Series Program
eftekhar.eftekharpour(a)umanitoba.ca
<mailto:eftekhar.eftekharpour@umanitoba.ca>
******************************************
<http://www.manitobaneuroscience.ca/>
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
<https://www.instagram.com/manitobaneuroscience/>
<https://twitter.com/manitobaneuro>